Big Move For Soligenix, Inc.
Thu, Nov 30, 2023 at 07:42 PM
Soligenix, Inc. (SNGX:NASDAQ) soared at $0.98, a gain of 136%. On Thu, Nov 30, 2023, SNGX:NASDAQ touched a New 2-Week High of $0.98. The stock appeared on our News Catalysts scanner on Thu, Nov 30, 2023 at 09:23 AM in the 'BIOTECH' category. From Thu, Nov 16, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Thu, Nov 30, 2023 at $2 with a volume of 98M+.
About Soligenix, Inc. (SNGX:NASDAQ)
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Top 10 Gainers:
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 193.89%
- Signature Bank (SBNY:NASDAQ), 150%
- Soligenix, Inc. (SNGX:NASDAQ), 135.97%
- Incannex Healthcare Limited (IXHL:NASDAQ), 84.95%
- ImmunoGen, Inc. (IMGN:NASDAQ), 82.75%
- SeaChange International, Inc. (SEAC:NASDAQ), 74.22%
- Intelligent Bio Solutions Inc Com (INBS:NASDAQ), 61.35%
- Smart for Life Inc. (SMFL:NASDAQ), 58.55%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 53.38%
- Etao International Co. Ltd. (ETAO:NASDAQ), 50.6%